Clinical Trial Update: Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing reduced-dose radiotherapy with and without concurrent chemotherapy versus standard concurrent chemoradiation for high-risk locally adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Standard concurrent chemoradiation

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, De-escalation Therapy | Phase 3 | Status: RECRUITING